BackSilence Therapeutics Plc Overview

Silence Therapeutics Plc Current Cash

Track Silence Therapeutics Plc's current cash ($5.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$5.66M
↓ 91.28% YoYΔ $-59.23M vs prior year quarter

Peer average

Loading

Silence Therapeutics Plc Current Cash History

Loading

Silence Therapeutics Plc vs. peers: Current Cash Comparison

Loading

Silence Therapeutics Plc Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Silence Therapeutics Plc (SLN) FAQ

Silence Therapeutics Plc (SLN) currently reports a current cash of $5.7M as of March 2026. That compares with $65M in the prior-year period — down 91.3% year over year. Use the charts on this page to explore Silence Therapeutics Plc's current cash history and peer comparisons.

Silence Therapeutics Plc's current cash decreased from $65M to $5.7M — a 91.3% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Silence Therapeutics Plc reported $5.7M in current cash as of March 2026. That compares with $65M in the prior-year period — down 91.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $5.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Silence Therapeutics Plc, and consider following SLN for alerts when major investors trade the stock.

Silence Therapeutics Plc is classified in the Healthcare sector. On current cash, it currently shows $5.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SLN with unrelated industries.